2,4-diaminoquinazoline has been researched along with Trypanosomiasis, African in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bishop, OT; Boyom, FF; Dize, D; Duffy, J; Fokou, PVT; Keumoe, R; Kouipou Toghueo, RM; Laleu, B; Njanpa, CN; Tata, RB; Tchatat, MB; Tchuenguia, VC; Yamthe, LT | 1 |
1 other study(ies) available for 2,4-diaminoquinazoline and Trypanosomiasis, African
Article | Year |
---|---|
Preliminary Structure-Activity Relationship Study of the MMV Pathogen Box Compound MMV675968 (2,4-Diaminoquinazoline) Unveils Novel Inhibitors of
Topics: Animals; Humans; Iron; Ligands; Quinazolines; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Trypanocidal Agents; Trypanosoma; Trypanosoma brucei brucei; Trypanosomiasis, African | 2022 |